The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 15, No. 12, pp. 996-998.
© 1981 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, T.


Research Articles

Urinary hesitancy with therapeutic doses of L-tryptophan

TN Rubin

L-tryptophan, a precursor of serotonin, in doses of 4 to 5 g/d, has been found to be effective in increasing sleep time, reducing sleep latency, and reducing the number of awakenings. In this report, L-tryptophan 4-6 g/d was administered, along with niacinamide 100 mg and pyridoxine 50 mg, for sleep. Two days after starting L-tryptophan, the patient reported difficulty in voiding. Medications with known anticholinergic activity were selectively discontinued during the patient's hospital course. Seven days after the last dose of L-tryptophan, improvement was noted in the patient's urinary status. Prior to discharge, doxepin was restarted and titrated up to 150 mg/d without a recurrence of urinary problems.





homecopy help contact us subscription past issues search current issue
Copyright © 1981 by Harvey Whitney Books Company.